Varicella-Zoster virus (VZV) Printer Friendly

back Clinical Background Clinical Utility Assay Principle Results Sample Requirements Case Tutorial References forward
  Written by: Alexandra Valsamakis, M.D., Ph.D.


Clinical Background:

Varicella-Zoster virus (VZV) is a human herpes DNA virus, type 3. The virus is transmitted by aerosols, is a highly contagious, infects mucous membranes, skin and neurons and causes chicken pox (Varicella). Recurrent infection resulting from reactivation of virus incorporated in the genome of satellite cells surrounding dorsal root ganglia causes shingles (Zoster). The chickenpox rash occurs two weeks after respiratory infection with the virus and is characterized by the classic dermatologic finding of macules, which progress to vesicles resembling "a dew drop on a rose petal." Primary and recurrent infection is generally self-limited.

Anti-viral treatment of VZV is indicated in immunocompromised patients and pregnant women in their third trimester. Therapy is also instituted if VZV pneumonitis, corneal or trigeminal ganglion involvement is present in immunocompetent individuals. Encephalitis is an infrequent complication.

 









Homepage | Site Info | Contact Us | Links | Search

Pathology Homepage
Copyright © 1999 - 2005 The Johns Hopkins University
All rights reserved. No part of this website may be reproduced in any
form or by any means or incorporated into any information retrievel system,
electronic or mechanical, without the written permission of JHU.